ATE173624T1 - Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten - Google Patents

Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten

Info

Publication number
ATE173624T1
ATE173624T1 AT95929328T AT95929328T ATE173624T1 AT E173624 T1 ATE173624 T1 AT E173624T1 AT 95929328 T AT95929328 T AT 95929328T AT 95929328 T AT95929328 T AT 95929328T AT E173624 T1 ATE173624 T1 AT E173624T1
Authority
AT
Austria
Prior art keywords
halcinonide
triamcinoloneacetonide
pharmaceutical compositions
compositions containing
synergistic pharmaceutical
Prior art date
Application number
AT95929328T
Other languages
English (en)
Inventor
Georges Chriki
Original Assignee
Psorial Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psorial Llc filed Critical Psorial Llc
Application granted granted Critical
Publication of ATE173624T1 publication Critical patent/ATE173624T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95929328T 1994-07-28 1995-07-27 Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten ATE173624T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28164294A 1994-07-28 1994-07-28
US08/469,371 US5707981A (en) 1994-07-28 1995-06-06 Synergistic pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE173624T1 true ATE173624T1 (de) 1998-12-15

Family

ID=26961006

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95929328T ATE173624T1 (de) 1994-07-28 1995-07-27 Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten

Country Status (6)

Country Link
US (2) US5707981A (de)
EP (1) EP0840613B1 (de)
AT (1) ATE173624T1 (de)
AU (1) AU3271795A (de)
GR (1) GR3029474T3 (de)
WO (1) WO1996003132A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428814B1 (en) 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
US6969529B2 (en) 2000-09-21 2005-11-29 Elan Pharma International Ltd. Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
US7198795B2 (en) 2000-09-21 2007-04-03 Elan Pharma International Ltd. In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
JP4598399B2 (ja) 2002-02-04 2010-12-15 エラン ファーマ インターナショナル，リミティド 表面安定剤としてリゾチームを有するナノ粒子組成物
US6900058B2 (en) * 2003-03-11 2005-05-31 Bionostics, Inc. Control solution for photometric analysis
US20070196452A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Flux-enabling compositions and methods for dermal delivery of drugs
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990401A (en) * 1958-06-18 1961-06-27 American Cyanamid Co 11-substituted 16alpha, 17alpha-substituted methylenedioxy steroids
US3035050A (en) * 1960-08-19 1962-05-15 Olin Mathieson 1-dehydrogenation of 11beta-hydroxy steroids by 2, 3-dibromo-5, 6-dicyanoquinone
GB970440A (en) * 1961-08-14 1964-09-23 Merck & Co Inc Anti-inflammatory compositions comprising steroids and indole derivatives
DE2323744C3 (de) * 1972-05-13 1978-11-23 J. Uriach & Cia., S.A., Barcelona (Spanien) 4,4'-Bismethylen-(3-methoxy-2-naphthoesäure-triamcinolon-acetonidester) und Verfahren zu dessen Herstellung
US4107161A (en) * 1972-05-13 1978-08-15 J. Uriach & Cia. S.A. Bis(triamcinolone acetonide)-4,4'-methylenebis-(3-methoxy-2-naphthoate)
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4233295A (en) * 1979-05-31 1980-11-11 E. R. Squibb & Sons, Inc. Corticosteroid formulations containing sebacate carrier
GB8420771D0 (en) * 1984-08-15 1984-09-19 Efamol Ltd Treatment of skin disorders
EP0196121A1 (de) * 1985-02-22 1986-10-01 Pera Dr. Visnjic Verfahren zur Herstellung des Präparats für die Behandlung der Krankheit Psoriasis; Arzneimittel für die Behandlung von Psoriasis und seine Anwendung
DE4119170C2 (de) * 1991-06-11 2002-04-25 Geb Herber Miltner Mittel gegen Neurodermitis

Also Published As

Publication number Publication date
WO1996003132A1 (en) 1996-02-08
EP0840613A1 (de) 1998-05-13
GR3029474T3 (en) 1999-05-28
US5707981A (en) 1998-01-13
USRE36606E (en) 2000-03-07
AU3271795A (en) 1996-02-22
EP0840613B1 (de) 1998-11-25

Similar Documents

Publication Publication Date Title
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
TW355683B (en) Composition containing micronized nebivolol
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
GEP20043161B (en) Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
IL105017A0 (en) Pharmaceutical composition containing a defined lipid system
MX166477B (es) Composiciones orales
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
WO1994019005A1 (de) Pharmazeutische oder kosmetische, enzyme umfassende zubereitung, verfahren zu deren herstellung und deren verwendung
HK1021539A1 (en) Androstene derivatives.
ATE148630T1 (de) Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen
MX9307509A (es) Metodo y preparacion farmaceutica para reducir la actividad de las celulas.
ATE173624T1 (de) Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
CA2173147A1 (en) Anti-obesity agent
GEP20043162B (en) Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
IE781032L (en) Pharmaceutical compositions
CA2030962A1 (en) Improvements relating to the administration of pharmaceutical agents
TW372193B (en) Novel pharmaceutical composition for the preparation of a stable powder containing an association of acetylsalicylic acid and metoclopramide as the active ingredient
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
IL106288A0 (en) Skin regenerating cosmetic compositions
HRP20020258B1 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
MX9306296A (es) Composiciones anestesicas y su uso.
ATE285782T1 (de) Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification